IPO
SPAC regime reflects HK's cautious approach to expansion - AVCJ Forum
The Hong Kong Stock Exchange (HKEx) is positioning its soon-to-launch special purpose acquisition company (SPAC) regime as part of efforts to broaden its appeal in terms of capital markets tools and geographies. At the same time, executives are wary of...
NetEase music spinout completes $449m Hong Kong IPO
Cloud Village, a music streaming business controlled by Chinese internet giant NetEase and backed by several private equity investors, has raised HK$3.5 billion ($449 million) through a Hong Kong IPO.
China IPOs: The star still wanes
Proceeds from private equity-backed offerings on China’s Star Market are down 75% from their peak one year ago, reflecting ongoing regulatory interference and diminished investor confidence
PE-backed Paytm raises $2.5b in India's largest-ever IPO
Indian digital payments platform Paytm completed the country’s largest-ever IPO – raising INR183 billion ($2.47 billion) – but then saw its stock fall 27% on debut.
Baring, Quadrant claim firm of the year prizes at AVCJ Awards
Baring Private Equity Asia (BPEA) and Quadrant Private Equity won the firm of the year prizes at the 2021 AVCJ Private Equity & Venture Capital Awards, as KKR and NewQuest Capital Partners secured two victories apiece, and Weijian Shan received the AVCJ...
India's Nykaa trades up after $719m IPO
India-based beauty e-commerce platform Nykaa is trading at more than 100% premium to its IPO price after completing a INR53.5 billion ($719 million) offering that facilitated partial exits for TPG Capital and Lighthouse Funds.
North Asia IPOs: Welcome eruptions
A steady rhythm of small and mid-sized IPOs in North Asia is now being punctuated by globally noticeable events. Valuations are up, but Korean and Japanese investors are game
Southeast Asia IPOs: Opportunity knocks
A breakthrough offering in Indonesia and regulatory progress in Singapore highlight Southeast Asia’s growing viability as a tech IPO market. It’s unclear how well this is being communicated globally
Hong Kong IPOs: Winner by default
New York’s loss is expected to be Hong Kong’s gain as regulatory and political turbulence drives Chinese start-ups to look for alternative listing destinations – unless valuations become a sticking point
PE-backed Delhivery files for India IPO
India-based e-commerce logistics provider Delhivery is looking to raise up to INR74.6 billion ($1 billion) through a domestic IPO that would facilitate partial exits for The Carlyle Group, Fosun Group, SoftBank Vision Fund 1, and Times Internet.
PE-owned APM Human Services set for $743m Australia IPO
APM Human Services, an Australia-based employment services provider with operations in 10 countries, is looking to raise A$986.2 million ($743 million) through a domestic IPO that will facilitate a partial exit for Madison Dearborn Partners (MDP).
SPACs: Longer menu
As the US recovers from a glut in SPAC fundraising, Asian jurisdictions are launching their own regimes. Not every start-up is a good fit for New York. Is Singapore or Hong Kong a good fit for them?
Hahn & Co's K Car raises $285m in Korean IPO
K Car, a Korean automotive marketplace created by Hahn & Company through the merger of SK Encar and Joy Rent a Car, has raised KRW336.6 billion ($285 million) in a domestic IPO.
PE-backed Abbisko trades up after $225m Hong Kong IPO
China-based oncology drug developer Abbisko Therapeutics gained nearly 10% on its Hong Kong trading debut following a HK$1.75 billion ($225 million) IPO.
3Q analysis: India advances
India technology investment continues to ramp up as China flatlines; international payments M&A drives Asia trade sale revival, but IPOs slump; fundraising remains slow
Stonebridge Ventures targets Korea IPO
Stonebridge Ventures, a Korean venture capital firm with more than KRW700 billion ($595 million) in assets under management, has filed to list on KOSDAQ.
China in six trends
Key themes in China private equity fundraising, investment, and exits
PE-backed MicroTech Medical targets $254m Hong Kong IPO
MicroTech Medical, a China-based manufacturer of insulin pumps for diabetes sufferers that counts Lilly Asia Ventures (LAV) and Qiming Venture Partners among its investors, is looking to raise up to HK$1.98 billion ($254 million) in a Hong Kong IPO.
China biotech start-up LianBio files for US IPO
LianBio, a two-year-old Chinese biotech start-up incubated by life sciences investor Perceptive Advisors, has filed for a US IPO.
Q&A: Poema Global's Homer Sun
Morgan Stanley Private Equity Asia’s former CIO explains why he likes special purpose acquisition companies (SPACs) and what drew him to electric scooter and mobility technology player Gogoro
PE-backed Oyo targets $1.1b India IPO
Oyo, an India-focused budget hotel platform backed by the likes of SoftBank Vision Fund, is looking to raise up to INR84.3 billion ($1.1 billion) through a domestic IPO.
Evergrande EV unit cancels listing, suffers cash crunch
Evergrande New Energy Vehicle (NEV) Group, the Hong Kong-listed electric vehicle unit of troubled Chinese real estate developer Evergrande has canceled a planned secondary listing on Shanghai's Star Market and warned investors of a cash shortage.
China's Broncus raises $215m in IPO, struggles on HK debut
Broncus Holding Corporation, a China-based manufacturer of medical devices used to treat lung diseases, plunged 12.8% on its Hong Kong trading debut following a HK$1.67 billion ($215 million) IPO.
India's Freshworks flourishes on NASDAQ debut
Freshworks, one of India's leading software-as-a-service (SaaS) businesses, traded strongly on its NASDAQ debut following a $1 billion IPO.